Dermatology News

Patients with autoimmune disease demonstrate a 30% higher risk for perinatal depression, while those with perinatal depression have a 30% higher risk for subsequent autoimmune disease, according to data published in Molecular Psychiatry.

Transgender and gender-diverse individuals reported experiencing rejection and discrimination due to acne, as well as unique barriers to acne care, according to study results published in JAMA Dermatology.

Researchers have developed and piloted a centralized care coordination program to prevent cardiovascular events in patients with psoriatic disease, according to a study.

The CDC on Thursday urged physicians to be judicious in prescribing topical antifungals in light of the recent detection of antimicrobial-resistant superficial fungal infections in the United States.

CVS Caremark, one of the nation’s largest pharmacy benefit managers, will remove Humira from its major national commercial formularies effective April 1 in favor of biosimilar options, according to a press release from the company.

Early data from a phase 1/2 trial showed promising results for AIV001, AiViva Biopharma’s intradermal basal cell carcinoma treatment, according to a company press release.

Patients reported low overall satisfaction with New Zealand’s mandatory nationwide transition to an adalimumab biosimilar, though most said they are still taking it and appreciated its less-painful injections, according to a study.

In this edition, an advocacy group petitions the FDA for stronger safety warnings for Botox, melanoma regression is associated with improved prognosis and more.

Among patients with psoriatic arthritis treated with guselkumab, early joint improvement by week 8 predicts lower radiographic progression rates through 2 years, according to data published in Clinical Rheumatology.

Following HHS’ blockbuster announcement of the first 10 drugs that would be subject to Medicare price negotiations, patients and providers alike have been looking forward to meaningful reductions in their costly treatments.